Decoy Therapeutics (DCOY) Total Non-Current Liabilities (2014 - 2019)
Decoy Therapeutics (DCOY) posted quarterly Total Non-Current Liabilities of $3.0 million for Q4 2019, down 36.54% quarter-over-quarter from $4.7 million in Q3 2019.
Decoy Therapeutics (DCOY) Total Non-Current Liabilities (2014 - 2019) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Total Non-Current Liabilities for 4 consecutive years, with $3.0 million the latest figure, recorded in Q4 2019.
- In Q4 2019, Total Non-Current Liabilities changed N/A year-over-year to $3.0 million; the TTM figure through Dec 2019 stood at $3.0 million (changed N/A YoY), while the FY2019 annual figure was $3.0 million, changed N/A from the prior year.
- Total Non-Current Liabilities slipped to $3.0 million in Q4 2019 per DCOY's latest filing, from $4.7 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $4.7 million in Q3 2019 and bottomed at $1.4 million in Q1 2015.
- Historically, Total Non-Current Liabilities has averaged $3.1 million across 3 years, with a median of $3.0 million in 2016.
- Annual changes were most pronounced in 2015 — Total Non-Current Liabilities jumped 159.44% — and 2016, when it soared 36.18%.
- Decoy Therapeutics' Total Non-Current Liabilities stood at $2.9 million in 2015, then jumped by 36.18% to $3.9 million in 2016, then retreated by 23.14% to $3.0 million in 2019.
- Business Quant data shows DCOY's Total Non-Current Liabilities at $3.0 million in Q4 2019, $4.7 million in Q3 2019, and $3.9 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 40.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 3.92 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.88 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.17 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.32 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 724.15 Mn |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 3.00 Mn |
| Sep 30, 2019 | 4.72 Mn |
| Dec 31, 2016 | 3.90 Mn |
| Sep 30, 2016 | 3.92 Mn |
| Jun 30, 2016 | 3.41 Mn |
| Mar 31, 2016 | 3.07 Mn |
| Dec 31, 2015 | 2.86 Mn |
| Sep 30, 2015 | 2.35 Mn |
| Jun 30, 2015 | 2.14 Mn |
| Mar 31, 2015 | 1.45 Mn |
| Dec 31, 2014 | 1.10 Mn |